VSEE News & Events

VSee Health announces that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million. This growth in the VSee hospital network has been driven by expanding Integrated Delivery Network relationships and multi-year deployments. VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented, "We have become a pure-play enterprise telehealth provider and are at a major inflection point having reached 58 hospitals. We expect to continue to expand our reach to hundreds of hospitals over the next two years. We are perfectly positioned to achieve a $20 million annual revenue run-rate, sustained gross margins of at least 50% and progress toward profitability."

VSee Health provided an update on its business operations and financials following its strategic sale of VSee Lab on May 31. Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions: +60% revenue growth to $8M in 2025; +70% revenue growth to $2.5M in Q1 2026; Approximate reduction of $6M in annual operating expenses. Several large IDN multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services. CEO Imoigele Aisiku commented, "Nearly one month since our decision to separate out VSee Lab and we are already seeing improved operational and financial efficiencies. Our team is super driven to ramp and grow existing contracts and identify, prospect and close new contracts from our ever-expanding business pipeline. With our hospital network continuing to grow, margins continuing to improve and operating expenses continuing to be reduced, we believe can achieve $20M revenue and profitability over the next 12 months is a realistic target."

VSee Health announced the completion of a strategic transaction that separates the company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses. Under a Stock Purchase Agreement dated May 31, VSee Health sold 100% of VSee Lab to former Co-CEO and Chairman Milton Chen. In connection with the transaction, Chen transferred all 2,870,069 shares of VSee Health common stock owned by him back to the company and assumed responsibility for the remaining liabilities of VSee Lab following closing. The returned shares represent approximately 7% of the company's outstanding common stock and are expected to significantly improve shareholder alignment while simplifying the company's capital structure. Concurrent with the closing, Chen resigned as Co-CEO and Chairman of the Board. Imoigele Aisiku has assumed the roles of sole CEO and Chairman of the Board and will lead the next phase of the Company's growth strategy.

VSEE Health announced a strategic managed services partnership with GoMyRx designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide. GoMyRx currently operates a national prescription fulfillment platform supporting annual gross transaction volume exceeding $10M, providing existing operational scale and infrastructure capacity to support the expanded partnership. Under the managed services agreement, GoMyRx will serve as VSEE Health's primary operational integration partner supporting prescription workflow coordination, medication fulfillment operations, and direct-to-patient delivery services connected to VSEE Health's enterprise telehealth infrastructure.